The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biological Multiplex Assays Market Research Report 2025
Synopsis
Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay.
The global Biological Multiplex Assays market was valued at US$ 65 million in 2023 and is anticipated to reach US$ 86 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
By geography, North America is expected to account for the largest share of the multiplex assays market in 2018, followed by Europe.
This report aims to provide a comprehensive presentation of the global market for Biological Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Multiplex Assays.
Report Scope
The Biological Multiplex Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biological Multiplex Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Laboratories
Qiagen
Abcam
Becton Dickinson
Merck
Agilent Technologies
Meso Scale Diagnostics
Randox Laboratories
Quanterix
Bio-Techne
Olink
Segment by Type
Protein Assays
Nucleic Acid Assays
Segment by Application
Research And Development
Clinical Diagnosis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biological Multiplex Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay.
The global Biological Multiplex Assays market was valued at US$ 65 million in 2023 and is anticipated to reach US$ 86 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
By geography, North America is expected to account for the largest share of the multiplex assays market in 2018, followed by Europe.
This report aims to provide a comprehensive presentation of the global market for Biological Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Multiplex Assays.
Report Scope
The Biological Multiplex Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biological Multiplex Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Laboratories
Qiagen
Abcam
Becton Dickinson
Merck
Agilent Technologies
Meso Scale Diagnostics
Randox Laboratories
Quanterix
Bio-Techne
Olink
Segment by Type
Protein Assays
Nucleic Acid Assays
Segment by Application
Research And Development
Clinical Diagnosis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biological Multiplex Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biological Multiplex Assays Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Protein Assays
1.2.3 Nucleic Acid Assays
1.3 Market by Application
1.3.1 Global Biological Multiplex Assays Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research And Development
1.3.3 Clinical Diagnosis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biological Multiplex Assays Market Perspective (2019-2030)
2.2 Biological Multiplex Assays Growth Trends by Region
2.2.1 Global Biological Multiplex Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biological Multiplex Assays Historic Market Size by Region (2019-2024)
2.2.3 Biological Multiplex Assays Forecasted Market Size by Region (2025-2030)
2.3 Biological Multiplex Assays Market Dynamics
2.3.1 Biological Multiplex Assays Industry Trends
2.3.2 Biological Multiplex Assays Market Drivers
2.3.3 Biological Multiplex Assays Market Challenges
2.3.4 Biological Multiplex Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biological Multiplex Assays Players by Revenue
3.1.1 Global Top Biological Multiplex Assays Players by Revenue (2019-2024)
3.1.2 Global Biological Multiplex Assays Revenue Market Share by Players (2019-2024)
3.2 Global Biological Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biological Multiplex Assays Revenue
3.4 Global Biological Multiplex Assays Market Concentration Ratio
3.4.1 Global Biological Multiplex Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biological Multiplex Assays Revenue in 2023
3.5 Biological Multiplex Assays Key Players Head office and Area Served
3.6 Key Players Biological Multiplex Assays Product Solution and Service
3.7 Date of Enter into Biological Multiplex Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biological Multiplex Assays Breakdown Data by Type
4.1 Global Biological Multiplex Assays Historic Market Size by Type (2019-2024)
4.2 Global Biological Multiplex Assays Forecasted Market Size by Type (2025-2030)
5 Biological Multiplex Assays Breakdown Data by Application
5.1 Global Biological Multiplex Assays Historic Market Size by Application (2019-2024)
5.2 Global Biological Multiplex Assays Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biological Multiplex Assays Market Size (2019-2030)
6.2 North America Biological Multiplex Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biological Multiplex Assays Market Size by Country (2019-2024)
6.4 North America Biological Multiplex Assays Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biological Multiplex Assays Market Size (2019-2030)
7.2 Europe Biological Multiplex Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biological Multiplex Assays Market Size by Country (2019-2024)
7.4 Europe Biological Multiplex Assays Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biological Multiplex Assays Market Size (2019-2030)
8.2 Asia-Pacific Biological Multiplex Assays Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biological Multiplex Assays Market Size by Region (2019-2024)
8.4 Asia-Pacific Biological Multiplex Assays Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biological Multiplex Assays Market Size (2019-2030)
9.2 Latin America Biological Multiplex Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biological Multiplex Assays Market Size by Country (2019-2024)
9.4 Latin America Biological Multiplex Assays Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biological Multiplex Assays Market Size (2019-2030)
10.2 Middle East & Africa Biological Multiplex Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biological Multiplex Assays Market Size by Country (2019-2024)
10.4 Middle East & Africa Biological Multiplex Assays Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Luminex
11.1.1 Luminex Company Detail
11.1.2 Luminex Business Overview
11.1.3 Luminex Biological Multiplex Assays Introduction
11.1.4 Luminex Revenue in Biological Multiplex Assays Business (2019-2024)
11.1.5 Luminex Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Biological Multiplex Assays Introduction
11.2.4 Thermo Fisher Scientific Revenue in Biological Multiplex Assays Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Illumina
11.3.1 Illumina Company Detail
11.3.2 Illumina Business Overview
11.3.3 Illumina Biological Multiplex Assays Introduction
11.3.4 Illumina Revenue in Biological Multiplex Assays Business (2019-2024)
11.3.5 Illumina Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Biological Multiplex Assays Introduction
11.4.4 Bio-Rad Laboratories Revenue in Biological Multiplex Assays Business (2019-2024)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Biological Multiplex Assays Introduction
11.5.4 Qiagen Revenue in Biological Multiplex Assays Business (2019-2024)
11.5.5 Qiagen Recent Development
11.6 Abcam
11.6.1 Abcam Company Detail
11.6.2 Abcam Business Overview
11.6.3 Abcam Biological Multiplex Assays Introduction
11.6.4 Abcam Revenue in Biological Multiplex Assays Business (2019-2024)
11.6.5 Abcam Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Detail
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson Biological Multiplex Assays Introduction
11.7.4 Becton Dickinson Revenue in Biological Multiplex Assays Business (2019-2024)
11.7.5 Becton Dickinson Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Biological Multiplex Assays Introduction
11.8.4 Merck Revenue in Biological Multiplex Assays Business (2019-2024)
11.8.5 Merck Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Detail
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Biological Multiplex Assays Introduction
11.9.4 Agilent Technologies Revenue in Biological Multiplex Assays Business (2019-2024)
11.9.5 Agilent Technologies Recent Development
11.10 Meso Scale Diagnostics
11.10.1 Meso Scale Diagnostics Company Detail
11.10.2 Meso Scale Diagnostics Business Overview
11.10.3 Meso Scale Diagnostics Biological Multiplex Assays Introduction
11.10.4 Meso Scale Diagnostics Revenue in Biological Multiplex Assays Business (2019-2024)
11.10.5 Meso Scale Diagnostics Recent Development
11.11 Randox Laboratories
11.11.1 Randox Laboratories Company Detail
11.11.2 Randox Laboratories Business Overview
11.11.3 Randox Laboratories Biological Multiplex Assays Introduction
11.11.4 Randox Laboratories Revenue in Biological Multiplex Assays Business (2019-2024)
11.11.5 Randox Laboratories Recent Development
11.12 Quanterix
11.12.1 Quanterix Company Detail
11.12.2 Quanterix Business Overview
11.12.3 Quanterix Biological Multiplex Assays Introduction
11.12.4 Quanterix Revenue in Biological Multiplex Assays Business (2019-2024)
11.12.5 Quanterix Recent Development
11.13 Bio-Techne
11.13.1 Bio-Techne Company Detail
11.13.2 Bio-Techne Business Overview
11.13.3 Bio-Techne Biological Multiplex Assays Introduction
11.13.4 Bio-Techne Revenue in Biological Multiplex Assays Business (2019-2024)
11.13.5 Bio-Techne Recent Development
11.14 Olink
11.14.1 Olink Company Detail
11.14.2 Olink Business Overview
11.14.3 Olink Biological Multiplex Assays Introduction
11.14.4 Olink Revenue in Biological Multiplex Assays Business (2019-2024)
11.14.5 Olink Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
